Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.

Journal of cellular physiology - 1 Nov 1990

Cutts J L, Bankhurst A D

Abstract excerpt

The activation of human natural killer (NK) cell cytotoxicity by interleukin 2 (IL-2) is well established, although the biochemical mechanisms of this stimulation have not yet been fully delineated. Earlier, we reported that treatment of NK cells with an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase such as compactin or lovastatin significantly abrogates the in vitro killing of a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol
Share to Cytotoxicity, Immunologic
Share to DNA Replication

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to In Vitro Techniques

Share to Interleukin-2

Share to Phenotype

Share to Protein Biosynthesis

Share to Time Factors

Source

Identifiers

PMID: 2246324
DOI: 10.1002/jcp.1041450208

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.PMID 2246324Read ↗

NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.Semantic proximity Read ↗

Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2.Semantic proximity Read ↗

Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.Semantic proximity Read ↗

Monocyte-mediated suppression of IL-2-induced NK-cell activation. Regulation by 5-HT1A-type serotonin receptors.Semantic proximity Read ↗

Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha.Semantic proximity Read ↗

Regulation of the natural killer cell response to interferon-alpha by biogenic amines.Semantic proximity Read ↗

Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.Semantic proximity Read ↗

Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endothelium.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.